Skip to content
2000
Volume 19, Issue 1
  • ISSN: 1871-5249
  • E-ISSN: 1875-6166

Abstract

Background: Dual-acting human monoamine oxidase B (hMAO-B) and cholinesterase (ChE) inhibitors are more effective than the classic one-drug one-target therapy for Alzheimer’s disease (AD). Methods: The ChE inhibitory ability of some halogenated thiophene chalcone-based molecules known to be selective hMAO-B inhibitors was evaluated. Results: Based on the IC50 values, the selected compounds were found to moderately inhibit ChE, with IC50 values in the range of 14-70 μM. Among the synthesised molecules, T8 and T6 showed the most potent inhibitory activity against AChE and BChE, respectively. Conclusion: Taken together, the data revealed that T8 could be further optimized to enhance its AChE inhibitory activity.

Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/1871524918666181119114016
2019-04-01
2025-12-31
Loading full text...

Full text loading...

/content/journals/cnsamc/10.2174/1871524918666181119114016
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test